Clayton, Dubilier & Rice has named Nadav Tomer, a medical technology specialist, as an operating advisor to the firm’s funds.

Going forward, Tomer will advise the firm’s healthcare team to source new investments while advising the funds’ healthcare businesses. Tomer joins the firm with 22 years of leadership experience across the medical technology sector. Previously, Tomer served as a global president of Johnson & Johnson‘s DePuy Synthes Spine franchise where he drove global strategy, commercial execution, innovation, portfolio and brand management. While with J&J, Tomer focused on therapeutic areas within diabetes care, spine, cardiology, endovascular, orthopedics, and electrophysiology.

“Nadav brings a strong track record of execution and deep experience leading global businesses in the medical technology field across a range of therapeutic areas and disciplines,” said CD&R partner Derek Strum. “We believe he will be highly valuable in creating differentiated angles and enhancing our ability to underwrite high conviction, execution-based investment cases as we look to expand our investments in medical technology.”